Immuneering Corporation

NASDAQ: IMRX · Real-Time Price · USD
2.15
0.10 (4.88%)
At close: Jun 06, 2025, 3:59 PM
2.17
0.93%
After-hours: Jun 06, 2025, 05:20 PM EDT
4.88%
Bid 2.13
Market Cap 77.37M
Revenue (ttm) n/a
Net Income (ttm) -61.77M
EPS (ttm) -1.97
PE Ratio (ttm) -1.09
Forward PE -1.16
Analyst Buy
Ask 2.2
Volume 735,081
Avg. Volume (20D) 199,409
Open 2.02
Previous Close 2.05
Day's Range 2.01 - 2.38
52-Week Range 1.00 - 3.83
Beta 0.00

About IMRX

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IMRX
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for IMRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
2 months ago
+9.09%
Immuneering shares are trading higher. Needham rei... Unlock content with Pro Subscription
5 months ago
+0%
Immuneering shares are trading higher after the company released interim data from its Phase 2a trials of IMM-1-104 and IMM-6-415 in advanced RAS and RAF-mutant tumors.